Your browser doesn't support javascript.
loading
Left Ventricular Mass Index in End-Stage Renal Disease Patients during Hemodialysis and Continuous Ambulatory Peritoneal Dialysis.
Nguyen, Nghia Nhu; Van Duong, Phieu; Ngoc Mai, Tan Huynh; Vo, Nghia Hoang; Luong, Dinh Kim; Ngo, Toan Hoang.
Afiliación
  • Nguyen NN; Department of Internal Medicine, Faculty of Medicine, Can Tho University of Medicine and Pharmacy, Can Tho 900000, Vietnam.
  • Van Duong P; Department of Internal Medicine, Faculty of Medicine, Nam Can Tho University, Can Tho 900000, Vietnam.
  • Ngoc Mai TH; Department of Internal Medicine, Faculty of Medicine, Can Tho University of Medicine and Pharmacy, Can Tho 900000, Vietnam.
  • Vo NH; Department of Internal Medicine, Faculty of Medicine, Can Tho University of Medicine and Pharmacy, Can Tho 900000, Vietnam.
  • Luong DK; Department of Internal Medicine, Faculty of Medicine, Can Tho University of Medicine and Pharmacy, Can Tho 900000, Vietnam.
  • Ngo TH; Department of Internal Medicine, Faculty of Medicine, Can Tho University of Medicine and Pharmacy, Can Tho 900000, Vietnam.
Int J Clin Pract ; 2023: 8816478, 2023.
Article en En | MEDLINE | ID: mdl-38115951
ABSTRACT

Background:

One of the primary reasons for high mortality in end-stage renal disease (ESRD) is cardiovascular disease in patients with renal replacement therapy (RRT). Left ventricular hypertrophy (LVH) significantly predicts mortality and cardiovascular events.

Objectives:

We assess the left ventricular mass index change in two dialysis

methods:

hemodialysis (HD) and continuous ambulatory peritoneal dialysis (CAPD). The factors associated with increased left ventricular mass index (LVMI). Materials and

Methods:

We recruit more than 50 HD patients and 45 CAPD patients with LVH of similar age, gender, dialysis duration, and LVMI for one-year follow-up.

Results:

The LVMI in the group of HD patients after one year increased from 180.28 ± 45.32 g/m2 to 212.58 ± 66.22 g/m2 (p = 0.001), while the LVMI in the group of patients with CAPD increased from 190.16 ± 66.01 g/m2 to 197.42 ± 78 g/m2 (p = 0.32). Multivariable logistic regression analysis, we demonstrated that dialysis by HD (ß = -1,167, 95% CI 0.104-0.938, p = 0.036) and anemia treatment lower the goals (ß = 1.9566, 95% CI 1.466-34.094, p = 0.015) were two factors associated with the progression of the LVMI.

Conclusion:

The LVH of end-stage renal disease patients with HD treatment is worse than CAPD treatment after a follow-up in one year. Dialysis by periodic hemodialysis and anemia treatment that fails to achieve the goal are risk factors associated with increased progression of LVMI in patients with ESRD.
Asunto(s)
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Diálisis Peritoneal Ambulatoria Continua / Anemia / Fallo Renal Crónico Límite: Humans Idioma: En Revista: Int J Clin Pract Asunto de la revista: MEDICINA Año: 2023 Tipo del documento: Article País de afiliación: Vietnam Pais de publicación: India
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Diálisis Peritoneal Ambulatoria Continua / Anemia / Fallo Renal Crónico Límite: Humans Idioma: En Revista: Int J Clin Pract Asunto de la revista: MEDICINA Año: 2023 Tipo del documento: Article País de afiliación: Vietnam Pais de publicación: India